BIIB vs EXPI · P/E 21, rev $9.89B vs rev $4.57B
Biogen Inc (BIIB) versus eXp World Holdings Inc (EXPI) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
eXp World Holdings Inc (EXPI) is a real estate services company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported EXPI revenue for 2024-12-31 was $4.57B. Net income was -$21.3M. Revenue was up 6.9% from 2023-12-31 to 2024-12-31. EXPI currently screens at market cap $1.45B.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. EXPI currently screens at market cap $1.45B.
Not investment advice. Open the BIIB and EXPI stock pages for the full models.
Not investment advice.